Netherlands 3D Imaging Market Analysis Report 2022 to 2030

Netherlands 3D Imaging Market Analysis

$ 3999

Netherlands's 3D imaging market is projected to grow from $0.08 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by a solid healthcare infrastructure, a thriving research and development industry, and rising demand for new medical technology. The market is segmented by product, by application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Pie Medical Imaging.

ID: IN10NLDH001 CATEGORY: Digital Health GEOGRAPHY: Netherlands AUTHOR: Vidhi Upadhyay

Buy Now

Netherlands 3D Imaging Market Executive Summary

Netherlands's 3D imaging market is projected to grow from $0.08 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The Netherlands' healthcare system is of excellent quality, and it is consistently ranked in the top three of the Euro Health Consumer Index. In accordance with the World Health Organization Global Health Expenditure database, health expenditure per capita in the Netherlands increased from $6,009.47 in 2018 to $6,248.15 in 2019. It is substantially higher than in other European nations due to the Dutch health system, which coordinates the commercial and public sectors to offer residents cost-effective healthcare services. The Global Cancer Observatory 2020, out of a total population of 17.13 Mn the number of new cases of cancer was 0.13 Mn with 0.05 Mn deaths. Every year, over 60,000 patients in the Netherlands undergo radiation therapy for cancer.

A wide range of medical disorders, including cancer, cardiovascular disease, and orthopedic issues, are diagnosed and evaluated using 3D imaging. CT scans, MRIs, and PET scans are some of the most common diagnostic imaging techniques in the Netherlands. 3D imaging is utilized in the healthcare industry for diagnostics, planning and simulation, treatment guiding, image-guided procedures, and research and teaching. The Netherlands has a thriving 3D Imaging sector, with a diverse set of technology and applications in use throughout the country. A solid healthcare infrastructure, a thriving research and development industry, and rising demand for new medical technology all contribute to the market's strength.

In November 2019, The Netherlands Cancer Institute has been the first in Europe to provide radiation treatment to a cancer patient using a 3D MRI movie.

netherlands 3D imaging market analysis

Market Dynamics

Market Growth Drivers

Increasing demand for customized medicine, the rising frequency of chronic illnesses, and the need for more efficient and effective diagnostic and treatment options are some of the primary drivers of the 3D Imaging market in the Netherlands. Furthermore, the Dutch government has been supportive of the development and implementation of new medical technologies, such as 3D Imaging, which has contributed to the market's favorable growth environment.

Overall, the 3D Imaging market in the Netherlands is likely to grow in the future years as a result of technical improvements, changing demographics, and altering healthcare demands.

Market Restraints

The regulatory environment in the Netherlands is a hurdle for the 3D Imaging sector. While the Dutch government has typically supported the development and deployment of modern medical technology, the regulatory clearance procedure for new imaging technologies may be time-consuming and expensive. This might make it difficult for smaller or newer enterprises to enter the market with unique imaging solutions. Moreover, the high cost of some of the advanced imaging technologies may lead to uncertainty in healthcare providers regarding the return on investments and hence may restrict the expected market growth.

Competitive Landscape

Key Players

GE Healthcare
Siemens Healthineers
Philips Healthcare
Canon Medical Systems
Fujifilm Holdings Corporation
Hitachi Healthcare
Toshiba Medical Systems
Pie Medical Imaging (NLD)
Mint Medical (NLD)

Notable Deals

December 2021, Philips and IJsselland Hospital form a long-term technological collaboration that would focus on innovation, digitization, and optimization, and involves the procurement of patient monitoring and radiological technologies such as CT and MRI equipment.

Healthcare Policies and Regulatory Landscape

The Dutch Healthcare Authority (NZa) and the Dutch Medical Devices Act (Wet op Medische Hulpmiddelen) are in charge of 3D Imaging legislation in the Netherlands. The NZa is in charge of ensuring the quality and safety of healthcare services such as imaging. whereas the Medical Equipment Act governs the safety, performance, and quality of medical devices, including imaging software. Furthermore, the Ministry of Health, Welfare, and Sport (Ministerie van Volksgezondheid, Welzijn en Sport) establishes healthcare policy and regulations, including imaging. The policies seek to protect patient safety, foster innovation, and keep healthcare services of high quality.

Reimbursement Scenario

In the Netherlands, reimbursement for 3D Imaging is often covered by the national health insurance system. It includes diagnostic imaging such as X-rays, CT scans, and MRI scans as well as other medical treatments. Coverage and eligibility criteria may differ based on the individual's insurance plan and medical circumstances.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Netherlands 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

X-ray Imaging Systems
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

Cardiology
Neurology
Orthopedics
Gynecology
Oncology
Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

Hospitals
Diagnostic Imaging Centers
Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

Stationary
Mobile

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.